These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28651690)

  • 21. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhaled corticosteroids in subacute and chronic cough].
    Gasser S; von Elm E
    Praxis (Bern 1994); 2013 Oct; 102(21):1321-2. PubMed ID: 24129301
    [No Abstract]   [Full Text] [Related]  

  • 23. [Why are so many children with asthma poorly controlled by medicine? (interview by Dr. Judith Neumaier)].
    Schaub B
    MMW Fortschr Med; 2009 Apr; 151(17):6. PubMed ID: 20070061
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG; Georgiou A; Kampas D; Lemessios M; Markatos M; Adamidi T; Samara K; Skoula G; Damianaki A; Schiza S; Tzanakis N; Siafakas NM
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [You have a child with an unusual cough? Put your money on asthma].
    Hering T
    MMW Fortschr Med; 2004 Sep; 146(39):49-50. PubMed ID: 15532415
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summaries for patients. Omalizumab therapy for patients with severe asthma.
    Ann Intern Med; 2011 May; 154(9):I28. PubMed ID: 21536934
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma.
    Ohta K; Miyamoto T; Amagasaki T; Yamamoto M;
    Respirology; 2009 Nov; 14(8):1156-65. PubMed ID: 19909462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients.
    Domingo C; Moreno A; José Amengual M; Montón C; Suárez D; Pomares X
    Curr Med Res Opin; 2011 Jan; 27(1):45-53. PubMed ID: 21083517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Asthma in the elderly].
    Lindner K; Panaszek B; Machaj Z
    Pol Arch Med Wewn; 2007 Aug; 117(8):350-4. PubMed ID: 18018382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Kondla A; Glaab T; Pedersini R; Lommatzsch M
    Respir Med; 2016 Sep; 118():58-64. PubMed ID: 27578472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PROPER USE OF INHALED CORTICOSTEROIDS IN ADULT PATIENTS WITH ASTHMA].
    Niimi A
    Arerugi; 2016; 65(6):757-63. PubMed ID: 27439578
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis.
    Chandra RK; Clavenna M; Samuelson M; Tanner SB; Turner JH
    Int Forum Allergy Rhinol; 2016 May; 6(5):472-7. PubMed ID: 26679299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation.
    Caminati M; Gatti D; Dama A; Lorenzetti L; Senna G
    Ann Allergy Asthma Immunol; 2017 Nov; 119(5):460-462. PubMed ID: 28941707
    [No Abstract]   [Full Text] [Related]  

  • 35. A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.
    Garcia G; Magnan A; Chiron R; Contin-Bordes C; Berger P; Taillé C; Devouassoux G; de Blay F; Couderc LJ; Didier A; O'Callaghan DS; Girodet PO; Bourdeix I; Le Gros V; Humbert M
    Chest; 2013 Aug; 144(2):411-419. PubMed ID: 23579324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal.
    Contoli M; Bousquet J; Fabbri LM; Magnussen H; Rabe KF; Siafakas NM; Hamid Q; Kraft M
    Allergy; 2010 Feb; 65(2):141-51. PubMed ID: 19909298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary alveolar hypoventilation syndrome combined with severe obstructive sleep apnea hypopnea syndrome in a post-middle-aged patient.
    Hazama GI; Inoue Y; Higami S; Imaoko M; Kawahara R
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):582-3. PubMed ID: 15482593
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.
    Kharitonov SA
    Vascul Pharmacol; 2005 Dec; 43(6):371-8. PubMed ID: 16198155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omalizumab and Churg-Strauss syndrome.
    Giavina-Bianchi P; Giavina-Bianchi M; Agondi R; Kalil J
    J Allergy Clin Immunol; 2008 Jul; 122(1):217; author reply 217-8. PubMed ID: 18602576
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.